Rivastigmine transdermal patch is a drug used to treat Alzheimer's disease and Parkinson's related dementia. Its English name is Rivastigmine, also known as Exelon Patch. The drug was developed by Novartis in the United States and launched in the United States in 2007, but it has not yet been launched in China or included in medical insurance.
How much does Rivastigmine transdermal patch cost?
The price of Rivastigmine transdermal patch is the focus of many patients and their families. Understanding its price range helps to plan the treatment budget reasonably.
Market price reference
The German version of Rivastigmine transdermal patch exported by Novartis in Switzerland has a specification of 90 patches. This price may vary due to exchange rate fluctuations and different purchase channels.
Factors affecting the price
The price of Rivastigmine transdermal patch is affected by many factors, including manufacturers, specifications, purchase channels and regional differences. In addition, there are many generic drugs on the market, and their prices may be lower than the original drugs, but patients need to choose carefully and clarify the quality and efficacy of the drugs.
After understanding the price of rivastigmine transdermal patches, patients also need to pay attention to how to buy them through formal channels to avoid the risk of counterfeit drugs.
How to buy rivastigmine transdermal patches
Patients should also pay attention to the authenticity and safety of the drugs when purchasing.
Purchase channels
Patients can purchase rivastigmine transdermal patches through formal medical service institutions or cross-border e-commerce platforms. When choosing a channel, be sure to confirm its legality and reliability, and avoid purchasing from unknown sources to prevent buying counterfeit or inferior drugs.
Purchase precautions
When purchasing, you need to carefully check the production date, packaging integrity, and approval number of the drug. In addition, the storage conditions of the drug must also meet the requirements, such as light protection, moisture protection, temperature control, etc., to ensure that the efficacy is not affected.
After successfully purchasing rivastigmine transdermal patches, the correct method of use is the key to confirming the efficacy.
How to use rivastigmine transdermal patches
The usage and dosage of rivastigmine transdermal patches must strictly follow the doctor's instructions to clarify the treatment effect and reduce the occurrence of adverse reactions.
Initial dose and adjustment
Initial treatment should start with a dose of 4.6 mg/24 hours, applied to the skin once a day. Depending on the patient's tolerance, the dose can be gradually adjusted to 9.5 mg/24 hours or 13.3 mg/24 hours every 4 weeks. For patients with severe Alzheimer's disease, 13.3 mg/24 hours is the recommended dose.
Precautions for use
When replacing the patch, make sure that the old patch has been completely removed and avoid using multiple patches at the same time. If treatment is interrupted for more than 3 days, it is necessary to start again at a low dose. In addition, the patch should not be applied to the same part to reduce skin irritation.
The use of rivastigmine transdermal patch should be combined with the patient's specific situation and doctor's guidance to achieve the best treatment effect.
